8:22 AM
Leo Group India
| ||
| Valeant Pharmaceuticals Receives FTC Clearance For Medicis Acquisition Sacramento Bee MONTREAL, Nov. 16, 2012 -- /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that the U.S. Federal Trade Commission (FTC) has completed its review of the proposed acquisition of Medicis ... See all stories on this topic » | ||
| GoM on drug pricing policy likely to meet next week Economic Times After being unable to frame a policy for price control of essential drugs in its previous term, the UPA-II government had last year circulated a draft National Pharmaceutical Pricing Policy 2011 through the Department of Pharmaceuticals. The policy ... See all stories on this topic » | ||
| SKYSTAR BIO-PHARMACEUTICAL COMPANY : Skystar Bio-Pharmaceutical ... 4-traders Mr. Weibing Lu, Skystar Bio-Pharmaceutical's Chairman and Chief Executive Officer, commented, "Skystar has made significant strides in moving its infrastructure forward in support of manufacturing capacity for the Company's veterinary medication and ... See all stories on this topic » | ||
| Nehru College of Pharmacy organises PHARMACON IV 2012 on November 16 ... pharmabiz.com Nehru College of Pharmacy, Thrissur, Kerala has organised two-day sixth national pharmaceutical conference on recent trends in pharmaceutical research 'PHARMACON IV 2012' on November 16 and 17, 2012 at the college. The aim of this conference is to ... See all stories on this topic » | ||
| Tianyin Pharmaceutical's CFO Discusses F1Q 2013 Results - Earnings Call ... Seeking Alpha Good morning ladies and gentlemen, and welcome to the Tianyin Pharmaceutical Company's Q3 2012 Earnings Results Conference Call. (Operator instructions.) I would now like to turn the conference over to James Tong, Chief Financial Officer. Please go ... See all stories on this topic » | ||
| Catalyst Pharmaceutical Partners' net loss widens to USD2.62m in Q3 2012 MENAFN.COM Nov 16, 2012 (Menafn - M2 EQUITYBITES via COMTEX) --Pharmaceutical company Catalyst Pharmaceutical Partners Inc (nasdaqcm:CPRX) reported on Thursday its net loss of USD2.62m (USD0.08 per basic and diluted share) for the third quarter ended 30 ... See all stories on this topic » | ||
| Building on a Legacy: Vinita Gupta, CEO of Lupin Pharmaceuticals, Inc., Named ... Sacramento Bee BALTIMORE, Md., Nov. 15, 2012 /PRNewswire/ -- Vinita Gupta, CEO of Lupin Pharmaceuticals, Inc., was named the inaugural Ernst & Young U.S. 2012 Family Business Award of Excellence winner today at Ernst & Young LLP's 2012 Strategic Growth Forum ... See all stories on this topic » | ||
| Pa to get part of pharmaceutical settlement CBS 21 Attorney General Linda Kelly today announced that Pennsylvania will receive more than half a million dollars as part of a $95 million national settlement against a Connecticut pharmaceutical company. Kelly said the settlement resolves allegations that ... See all stories on this topic » | ||
| Reactions: Timothy Shiau Nature.com (blog) Timothy Shiau is an Assistant Director in the department of Drug Discovery, at NovaBay Pharmaceuticals and a Principal Chemist at Emeryville Pharmaceutical Services, and primarily works on topical antiinfective agents and NeutroPhase, a skin and wound ... See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment